Express Healthcare
Home  »  Events  »  Webinars  »  Value of NT-proBNP and Troponin in diagnosis & therapy management of heart failure patients | 29th September 2020

Loading Events

« All Events

  • This event has passed.

Value of NT-proBNP and Troponin in diagnosis & therapy management of heart failure patients | 29th September 2020

September 29, 2020 @ 2:00 pm - 3:00 pm

World Heart Day is celebrated every year on 29th September.

Cardiovascular Disorders (CVD), including heart disease and stroke, is the world’s leading cause of death claiming 17.9 million lives each year. Beginning of 2020, brought with itself the unheard novel corona virus with potentially severe consequences. Many trends emerged over the course of time and one such is that COVID-19 posed a particular risk to patients with underlying issues such as heart disease, which is already the leading cause of death in the planet.

Diagnosing heart failure (HF) in patients presenting in the Emergency Department (ED) is difficult. Clinical assessment of symptoms and signs has limited sensitivity and specificity. Often, patients are elderly with comorbidity, symptoms may be mild, and echocardiography may not be universally available. In such circumstances, cardiac biomarkers viz., NT-proBNP and Troponin tests in the ED aids in the correct identification and selecting the patient who need an echocardiographic study. In addition, it results in an optimization of healthcare resources for patients at risk of adverse events allowing for intensified care.


Take the opportunity to learn from the expert panelists:

  1. What is the trend in diagnosis of acute heart failure
  2. How can the natriuretic peptide NT-proBNP or BNP help in the diagnosis in dyspneic patients presented the ED
  3. Can it lower the diagnosis uncertainty and lower the rate of unnecessary imaging
  4. How can the natriuretic peptide, NT-proBNP or BNP be used for risk stratification
  5. What is the trend in therapy management of acute heart failure
  6. In therapy management of sacubitril/valsartan, can the natriuretic peptides – BNP and NT-proBNP be used with patients undergoing therapy
  7. Why is NT-proBNP more suitable to use

Who should attend?

  • Cardiologists
  • Critical Care Specialists
  • Emergency Physicians

Expert Panelists:

  • Dr. Sandeep Gore, Director, Emergency Medicine, Fortis Hospital, Mulund, Mumbai
  • Dr. (Col) Suvasish Chakraberty, Director, Emergency & Trauma Services, Artemis Hospital, Gurugram
  • Dr. Kiron Verghese, Professor and Head, Department Of Cardiology, Chief Interventional Cardiologist, St John’s Medical College, Bangalore
  • Dr. Sanjukta Dutta, Consultant and Head, Emergency Medicine Department, Fortis Hospital, Kolkata


September 29, 2020
2:00 pm - 3:00 pm
Event Category:
View Event Website


EH – Radiometer


Live Webinar
Leave A Reply

Your email address will not be published.

Attend an exclusive webinar to know more about biomarkers in diagnosis & therapy management of heart failure.
Register Now
 Introducing Smart Autoinjector: Changing the paradigm of usability, cost & size
Know More?
Are you looking for ICP-MS which can increase productivity and remove time trap from your analysis?
Know More